Prescription drug · ANDA
perphenazine NDC 70518-3257
Perphenazine 2 mg/1 · Tablet · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-3257-0 | 7051832570070518325700 | 30 TABLET in 1 BLISTER PACK (70518-3257-0)Marketed from Oct 27, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- perphenazine
- Generic name (nonproprietary)
- perphenazine
- Active ingredients
- Perphenazine — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205232
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 70518-3257_4edf31a2-9bed-f4ec-e063-6394a90a7d79SPL ID 4edf31a2-9bed-f4ec-e063-6394a90a7d79SPL set ID 1fc98e41-17d1-4491-87ed-ff7651422b5bRxCUI 198076UNII FTA7XXY4EZ
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518325700followed by a unit qualifier and the quantityPackage 70518-3257-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Perphenazine tablets, USP are indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine tablets, USP have not been shown effective for the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
About NDC 70518-3257
- What is NDC 70518-3257?
- 70518-3257 is the product NDC for perphenazine, Perphenazine 2 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- perphenazine.
- What is the active ingredient?
- Perphenazine.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for perphenazine?
- 72 other product NDCs are listed under this name. See all perphenazine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other perphenazine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4688 | 70518-4688-00 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4484 | 70518-4484-0070518-4484-02 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4144 | 70518-4144-00 |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4112 | 70518-4112-00 |
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-449 | 33342-0449-1133342-0449-15 |
| Perphenazine | Perphenazine 2 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-448 | 33342-0448-1133342-0448-15 |
| Perphenazine | Perphenazine 8 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-450 | 33342-0450-1133342-0450-15 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-451 | 33342-0451-1133342-0451-15 |
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Chartwell RX, LLC | 62135-799 | 62135-0799-90 |
| Perphenazine | Perphenazine 2 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-799 | 23155-0799-01 |
Other NDCs under ANDA 205232
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-694 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-695 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-696 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-697 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-591 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-592 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-593 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-594 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1041 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1042 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1043 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1044 |